OpenVSafe by OpenVAERS
Search V-safe

AEP-16307-39515

3 vaccinations 4 coded responses 6 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
600 / IL
Registered
2021-05-06
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Dose 1 — Moderna
  2. 2021-04-28
    Dose 2 — Moderna
  3. 2021-05-06
    Registered in v-safe
  4. 2021-05-06
    Survey response — day 7, dose 2
    MedDRA: Chills, Pyrexia — Feeling: Good · Site: Redness, Swelling, Itching · Chills, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Had chills, fever of 102F from 5pm 04/28/21 to 5:30pm 04/29/21 (vaccinated 11:20am on 04/28/21), had 5" diameter swelling, redness at site (Covid Arm) on 04/29/21 till 05/03/21, fatigue and spasms for two days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-05-06
    Report sent to call center — day 7, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-05-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-07-30
    Survey response — 3 months, dose 2
    MedDRA: Heavy menstrual bleeding, Intermenstrual bleeding — Feeling: Good
    Free text: Interim spotting between periods and heavier than normal bleeding for menstrual periods of three consecutive months after second dose on April 28, 2021 (not sure if this is in anyway related to the vaccination)
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  9. 2021-12-27
    Dose 3 — Moderna
  10. 2022-02-01
    Survey response — day 35, dose 3
    MedDRA: Intermenstrual bleeding — Feeling: Good
    Free text: Intermittent spotting (menstrual bleeding) between periods which starts from 15th day of cycle gradually increasing and lasting for the next 10-15 days
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-02-09
    Survey response — day 42, dose 3
    MedDRA: Intermenstrual bleeding, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Continued intermenstrual bleeding since 12/31/21 to 01/17/22 and then from 01/26/22 till date with daily gradual increase in discharge/bleeding · Healthcare visit (other): Ultrasound scheduled in two days
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-09
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2022-02-23

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Moderna
22021-04-28Moderna
32021-12-27Moderna No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 8 — day 7, dose 2

2021-05-06

Systemic reaction (other): Had chills, fever of 102F from 5pm 04/28/21 to 5:30pm 04/29/21 (vaccinated 11:20am on 04/28/21), had 5" diameter swelling, redness at site (Covid Arm) on 04/29/21 till 05/03/21, fatigue and spasms for two days

Release 9 — 3 months, dose 2

2021-07-30

Symptoms: Interim spotting between periods and heavier than normal bleeding for menstrual periods of three consecutive months after second dose on April 28, 2021 (not sure if this is in anyway related to the vaccination)

Release 11 — day 35, dose 3

2022-02-01

Symptoms: Intermittent spotting (menstrual bleeding) between periods which starts from 15th day of cycle gradually increasing and lasting for the next 10-15 days

Release 11 — day 42, dose 3

2022-02-09

Symptoms: Continued intermenstrual bleeding since 12/31/21 to 01/17/22 and then from 01/26/22 till date with daily gradual increase in discharge/bleeding
Healthcare visit (other): Ultrasound scheduled in two days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDHeavy menstrual bleeding ✓ · ✓
SDIntermenstrual bleeding ✓ · ✓
SROChills ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release